Home/Traverse Biotech/Olivier Audemard, MBA
OA

Olivier Audemard, MBA

Chief Financial Officer

Traverse Biotech

Therapeutic Areas

Traverse Biotech Pipeline

DrugIndicationPhase
CD3 X ROR2 DuoBodyMultiple Oncology IndicationsPreclinical
Targeting Innate ImmunityOncology and AgingResearch